Author:
Baweja Mukta,Arens Yotam,Herlitz Leal C.,Wyatt Christina
Publisher
Springer International Publishing
Reference81 articles.
1. Abbott KC, Hypolite IO, Welch PG, Agodoa LY (2001) Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 14(5):377
2. Abbott KC, Trespalacios FC, Agodoa LY, Ahuja TS (2003) HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS wave 2 study. BMC Nephrol 4:5.
https://doi.org/10.1186/1471-2369-4-5
3. Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane H, Eron J, Gill MJ, Horberg MA, Justice AC, Klein M, Mayor AM, Moore RD, Palella FJ, Parikh CR, Silverberg MJ, Golub ET, Jacobson LP, Napravnik S, Lucas GM, North American ACCoR, Design of the International Epidemiologic Databases to Evaluate A (2015) End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis 60(6):941–949.
https://doi.org/10.1093/cid/ciu919
4. Ahuja TS, Grady J, Khan S (2002) Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 13(7):1889–1893
5. Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, Rimland D, Rodriguez-Barradas MC, Dubrow R, Park LS, Skanderson M, Shiels MS, Gange SJ, Gebo KA, Justice AC, Veterans Aging Cohort S (2015) Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 60(4):627–638.
https://doi.org/10.1093/cid/ciu869